By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cellectis today announced the licensing of certain patents to Novartis covering certain uses of homologous recombination.

The deal grants the Swiss-based pharmaceutical firm patents for the family WO 90/11354. The technology belongs to the Pasteur Institute and Cellectis owns exclusive rights to them.

The technology allows researchers to introduce new characteristics into genomes.

Financial terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.